1-8 of 8
Jesus Gomez-Navarro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Rong Rong Huang, Jason Jalil, James S. Economou, Bartosz Chmielowski, Richard C. Koya, Stephen Mok, Hooman Sazegar, Elizabeth Seja, Arturo Villanueva, Jesus Gomez-Navarro, John A. Glaspy, Alistair J. Cochran, Antoni Ribas
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4101–4109.
https://doi.org/10.1158/1078-0432.CCR-11-0407
Published: 15 June 2011
View article titled, CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
Open the PDF for CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Tremelimumab (CP-675,206) in Patients with Advanced Refractory or Relapsed Melanoma

John M. Kirkwood, Paul Lorigan, Peter Hersey, Axel Hauschild, Caroline Robert, David McDermott, Margaret A. Marshall, Jesus Gomez-Navarro, Jane Q. Liang, Cecile A. Bulanhagui
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (3): 1042–1048.
https://doi.org/10.1158/1078-0432.CCR-09-2033
Published: 01 February 2010
View article titled, Phase II Trial of Tremelimumab (CP-675,206) in Patients with Advanced Refractory or Relapsed Melanoma
Open the PDF for Phase II Trial of Tremelimumab (CP-675,206) in Patients with Advanced Refractory or Relapsed Melanoma in another window
Journal Articles

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

Antoni Ribas, Begoña Comin-Anduix, Bartosz Chmielowski, Jason Jalil, Pilar de la Rocha, Tara A. McCannel, Maria Teresa Ochoa, Elizabeth Seja, Arturo Villanueva, Denise K. Oseguera, Bradley R. Straatsma, Alistair J. Cochran, John A. Glaspy, Liu Hui, Francesco M. Marincola, Ena Wang, James S. Economou, Jesus Gomez-Navarro
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6267–6276.
https://doi.org/10.1158/1078-0432.CCR-09-1254
Published: 30 September 2009
View article titled, Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Open the PDF for Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade

Antoni Ribas, Begoña Comin-Anduix, James S. Economou, Timothy R. Donahue, Pilar de la Rocha, Lilah F. Morris, Jason Jalil, Vivian B. Dissette, Itsushi Peter Shintaku, John A. Glaspy, Jesus Gomez-Navarro, Alistair J. Cochran
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 390–399.
https://doi.org/10.1158/1078-0432.CCR-08-0783
Published: 31 December 2008
View article titled, Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade
Open the PDF for Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade in another window
Includes: Supplementary data
Journal Articles

Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays

Begoña Comin-Anduix, Antonio Gualberto, John A. Glaspy, Elisabeth Seja, Maribel Ontiveros, Deborah L. Reardon, Roberto Renteria, Brigitte Englahner, James S. Economou, Jesus Gomez-Navarro, Antoni Ribas
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 107–116.
https://doi.org/10.1158/1078-0432.CCR-05-0136
Published: 05 January 2006
View article titled, Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays
Open the PDF for Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays in another window
Journal Articles

Strategies to Accomplish Targeted Expression of Transgenes in Ovarian Cancer for Molecular Therapeutic Applications

Enrique Casado, Jesus Gomez-Navarro, Masato Yamamoto, Yasuo Adachi, Candace J. Coolidge, Waleed O. Arafat, Shannon D. Barker, Minghui H. Wang, Parameshwar J. Mahasreshti, Akseli Hemminki, Manuel Gonzalez-Baron, Mack N. Barnes, Terri B. Pustilnik, Gene P. Siegal, Ronald D. Alvarez, David T. Curiel
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2496–2504.
Published: 01 August 2001
View article titled, Strategies to Accomplish Targeted Expression of Transgenes in Ovarian Cancer for Molecular Therapeutic Applications
Open the PDF for Strategies to Accomplish Targeted Expression of Transgenes in Ovarian Cancer for Molecular Therapeutic Applications in another window
Journal Articles

Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells versus Autologous Mesothelial Cells in Vitro

F. Joseph Kelly, C. Ryan Miller, Donald J. Buchsbaum, Jesus Gomez-Navarro, Mack N. Barnes, Ronald D. Alvarez, David T. Curiel
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4323–4333.
Published: 01 November 2000
View article titled, Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells <em>versus</em> Autologous Mesothelial Cells <em>in Vitro</em>
Open the PDF for Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells <em>versus</em> Autologous Mesothelial Cells <em>in Vitro</em> in another window
Journal Articles

A Cancer Gene Therapy Approach Utilizing an Anti-erbB-2 Single-Chain Antibody-encoding Adenovirus (AD21): A Phase I Trial

Ronald D. Alvarez, Mack N. Barnes, Jesus Gomez-Navarro, Minghui Wang, Theresa V. Strong, Waleed Arafat, Ramin B. Arani, Martin R. Johnson, Bruce L. Roberts, Gene P. Siegal, David T. Curiel
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (8): 3081–3087.
Published: 01 August 2000
View article titled, A Cancer Gene Therapy Approach Utilizing an Anti-erbB-2 Single-Chain Antibody-encoding Adenovirus (AD21): A Phase I Trial
Open the PDF for A Cancer Gene Therapy Approach Utilizing an Anti-erbB-2 Single-Chain Antibody-encoding Adenovirus (AD21): A Phase I Trial in another window